Stevanato Group S.p.A (STVN) Net Income towards Common Stockholders (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Net Income towards Common Stockholders of $32.8 million for Q1 2026, up 17.65% year-over-year from $27.9 million in Q1 2025, and down 40.72% on a QoQ basis from $55.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) has 7 years of Net Income towards Common Stockholders data on file, last reported at $32.8 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 17.65% year-over-year to $32.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.8 million (up 17.65% YoY) and the FY2025 annual result came in at $162.8 million, up 29.34% from the prior year.
- Net Income towards Common Stockholders declined to $32.8 million in Q1 2026 per STVN's latest filing, from $55.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $109.3 million in Q3 2023 and bottomed at $20.4 million in Q1 2024.
- The 5-year median for Net Income towards Common Stockholders is $51.6 million (2024), against an average of $57.2 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders sank 37.6%; it then soared 49.84% in 2025.
- Tracing STVN's Net Income towards Common Stockholders over 5 years: stood at $49.4 million in 2022, then dropped by 1.41% to $48.7 million in 2023, then advanced by 6.08% to $51.6 million in 2024, then gained by 7.22% to $55.4 million in 2025, then tumbled by 40.72% to $32.8 million in 2026.
- Per Business Quant, the three latest STVN Net Income towards Common Stockholders figures stand at $32.8 million (Q1 2026), $55.4 million (Q4 2025), and $107.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 398.73 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 135.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 13.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 130.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 112.77 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 72.77 Mn |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | 32.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.81 Mn |
| Dec 31, 2025 | 55.36 Mn |
| Sep 30, 2025 | 107.89 Mn |
| Jun 30, 2025 | 63.64 Mn |
| Mar 31, 2025 | 27.89 Mn |
| Dec 31, 2024 | 51.63 Mn |
| Sep 30, 2024 | 76.29 Mn |
| Jun 30, 2024 | 42.47 Mn |
| Mar 31, 2024 | 20.44 Mn |
| Dec 31, 2023 | 48.67 Mn |
| Sep 30, 2023 | 109.29 Mn |
| Jun 30, 2023 | 68.06 Mn |
| Mar 31, 2023 | 30.34 Mn |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 95.25 Mn |
| Jun 30, 2022 | 62.16 Mn |
| Mar 31, 2022 | 31.11 Mn |
| Dec 31, 2021 | 51.11 Mn |
| Sep 30, 2021 | 105.72 Mn |
| Jun 30, 2021 | 85.49 Mn |
| Mar 31, 2021 | 44.09 Mn |
| Dec 31, 2020 | 40.30 Mn |
| Sep 30, 2020 | 19.41 Mn |
| Jun 30, 2020 | 22.87 Mn |